Screener
ANI Pharmaceuticals ANIP Net debt / EBITDA
Net debt / EBITDA at other companies
Other financials
Where this comes from
Calculated from ANI Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001023024-26-000069
FAQ
- What is ANI Pharmaceuticals's net debt / EBITDA?
- ANI Pharmaceuticals (ANIP) reported net debt / EBITDA of -0.2× in Q2 2026.
- How has ANI Pharmaceuticals's net debt / EBITDA changed year-over-year?
- ANI Pharmaceuticals's net debt / EBITDA decreased by 121.7% year-over-year, from 1.1× to -0.2×.
- What is the long-term trend for ANI Pharmaceuticals's net debt / EBITDA?
- Over 5 years (2020 to 2025), ANI Pharmaceuticals's net debt / EBITDA has grown at a -51.2% compound annual growth rate (CAGR), from 6.2× to 0.2×.
- What does net debt / EBITDA mean?
- Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.
Ask your AI about ANI Pharmaceuticals's net debt / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude